STOCK TITAN

BlackRock ESG Capital Allocation Term Trust SEC Filings

ECAT NYSE

Welcome to our dedicated page for BlackRock ESG Capital Allocation Term Trust SEC filings (Ticker: ECAT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on BlackRock ESG Capital Allocation Term Trust's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into BlackRock ESG Capital Allocation Term Trust's regulatory disclosures and financial reporting.

Rhea-AI Summary

Saba Capital Management and affiliates report a large position in BlackRock ESG Capital Allocation Term Trust. The Schedule 13D/A (Amendment No. 26) shows that Saba Capital Management, L.P., Saba Capital Management GP, LLC and Boaz R. Weinstein collectively beneficially own 25,798,288 common shares, representing 25.97% of the trust’s outstanding common shares, based on 99,345,793 shares outstanding as of 6/30/25. The filing states that approximately $383,502,360 was paid to acquire these shares, using investor subscription proceeds, related capital appreciation and margin borrowings in the ordinary course of business. The funds and accounts advised by Saba Capital are entitled to dividends and sale proceeds on the shares, and recent trading activity from 11/25/25 to 1/21/26 is listed in an attached schedule.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported two open‑market sales of common stock. On January 15, 2026, it sold 80,452 shares at $15.97 per share. On January 16, 2026, it sold another 75,435 shares at $15.94 per share.

After these transactions, Saba Capital Management, L.P. reported beneficial ownership of 26,146,336 ECAT shares following the first sale and 26,070,901 shares following the second sale, all held indirectly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported selling common shares in two January 2026 transactions. On January 13, 2026, it sold 11,153 shares at a price of $15.92 per share, leaving 26,302,501 shares beneficially owned indirectly after that trade. On January 14, 2026, it sold a further 75,713 shares at $15.89 per share, bringing its indirect beneficial ownership to 26,226,788 ECAT shares following the second transaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Saba Capital Management, L.P., a more than 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported a sale of common shares. On January 6, 2026, Saba Capital sold 9,943 ECAT common shares at a price of $15.75 per share. After this transaction, Saba Capital beneficially owned 26,313,654 ECAT common shares, reported as held indirectly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported a small stock sale. On 01/02/2026, the firm sold 12,660 shares of ECAT common stock in an open-market transaction coded "S" at a price of $15.45 per share. After this transaction, Saba Capital reported beneficial ownership of 26,323,597 shares, held indirectly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

BlackRock ESG Capital Allocation Term Trust insider activity shows a small share sale by a large holder. On 12/24/2025, a reporting person associated with the trust sold 1,100 shares of common stock at a price of $15.57 per share, identified with transaction code "S" for a sale. After this transaction, the reporting person beneficially owned 26,336,257 shares, reported as indirect ownership.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported several recent transactions in the trust’s common shares. On November 28, 2025, Saba sold 9,389 indirect shares at $16.02 each. On the same date, 334,659 indirect shares were reduced at a price of $0, described as a pro-rata distribution in-kind for no consideration. After these moves, its indirectly owned position was 26,391,751 shares. On December 1, 2025, Saba sold an additional 54,394 indirect shares at $16.03, leaving it with 26,337,357 ECAT shares held indirectly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Saba Capital Management, L.P., a director and 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported a sale of common shares. On 11/26/2025, the reporting person sold 56,976 shares of ECAT common stock at a price of $16 per share, marked with transaction code "S" for a sale. Following this transaction, the reporting person reported 26,735,799 shares of ECAT common stock beneficially owned with indirect ownership.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported an open-market sale of the trust’s common stock. On 11/25/2025, the firm sold 49,669 ECAT common shares at a price of $15.8 per share, using transaction code "S" for a sale. After this transaction, Saba Capital Management, L.P. reported beneficial ownership of 26,792,775 ECAT common shares, held indirectly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Saba Capital Management and its affiliates have significantly increased their stake in BlackRock ESG Capital Allocation Term Trust (ECAT). The amended Schedule 13D/A (Amendment No. 25) reports that Saba Capital, Saba Capital Management GP, LLC, and Boaz R. Weinstein collectively beneficially own 26,842,444 common shares, representing 27.02% of ECAT’s outstanding common stock, based on 99,345,793 shares outstanding as of 6/30/25.

The filing states that approximately $399,024,176 was paid to acquire the ECAT common shares, using investor subscription proceeds, capital appreciation, and ordinary-course margin borrowings. All reported shares are held with shared voting and shared dispositive power, and the positions are owned by funds and accounts advised by Saba Capital, which are entitled to dividends and sale proceeds.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

How many BlackRock ESG Capital Allocation Term Trust (ECAT) SEC filings are available on StockTitan?

StockTitan tracks 114 SEC filings for BlackRock ESG Capital Allocation Term Trust (ECAT), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for BlackRock ESG Capital Allocation Term Trust (ECAT)?

The most recent SEC filing for BlackRock ESG Capital Allocation Term Trust (ECAT) was filed on January 22, 2026.